Evaxion Biotech A/S (EVAX) Business News Jan. 13, 2026, 13:00 UTC Evaxion expands AI-Immunology™ platform into autoimmune diseases Full text
Register to leave comments News bot Jan. 13, 2026, 1:08 p.m. 📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical